The US Food and Drug Administration (FDA) has approved a new pain medication, suzetrigine, marking the first new type of pain reliever to be approved in over 20 years.The drug, sold under the brand ...

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

The FDA approves Vertex's non-opioid oral pain signal inhibitor, Journavx, for treating adults with moderate-to-severe acute pain. Shares rise.

The U.S. Food and Drug Administration (FDA) on Thursday approved Journavx, the first new class of pain medication in more ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

GP Dr Roger Henderson provides an overview of the chronic complications of diabetes and the key preventive measures ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

Someone is considered to be diabetic if the blood glucose/sugar levels are persistently above normal. People with diabetes usually have problems converting food nutrients into energy for their body ...

In summary, preventing diabetic neuropathy involves a combination of good blood sugar control, regular exercise, a healthy diet, weight management, proper foot care, and routine medical check-ups.